US Bancorp’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

US Bancorp’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-687	Closed	–	–	3782
2018 Q4	$0	Hold	687	–	–	﹤0.01%	3842
2018 Q3	$1K	Hold	687	–	–	﹤0.01%	3615
2018 Q2	$1K	Hold	687	–	–	﹤0.01%	3596
2018 Q1	$1K	Hold	687	–	–	﹤0.01%	3590
2017 Q4	$2K	Hold	687	–	–	﹤0.01%	3513
2017 Q3	$2K	Hold	687	–	–	﹤0.01%	3471
2017 Q2	$2K	Hold	687	–	–	﹤0.01%	3441
2017 Q1	$2K	Hold	687	–	–	﹤0.01%	3443
2016 Q4	$3K	Hold	687	–	–	﹤0.01%	3363
2016 Q3	$3K	Hold	687	–	–	﹤0.01%	3331
2016 Q2	$2K	Hold	687	–	–	﹤0.01%	3450
2016 Q1	$3K	Hold	687	–	–	﹤0.01%	3344
2015 Q4	$3K	Hold	687	–	–	﹤0.01%	3408
2015 Q3	$3K	Hold	687	–	–	﹤0.01%	3409
2015 Q2	$3K	Hold	687	–	–	﹤0.01%	3414
2015 Q1	$5K	Hold	687	–	–	﹤0.01%	3314
2014 Q4	$2K	Buy	+687	New	+$2.77K	﹤0.01%	3449

US Bancorp's AST Position: Q1 2019 in Review

US Bancorp sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 687 shares.

US Bancorp first reported a position in AST in Q4 2014 and held it in 17 quarters. The position peaked at $5K in Q1 2015. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

US Bancorp reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
US Bancorp sold 687 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
US Bancorp first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 17 quarters.
US Bancorp's Asterias Biotherapeutics Inc. Series A position peaked at $5K in Q1 2015.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on US Bancorp's 13F filing for Q1 2019, filed 8 May 2019.